NovaBay Pharmaceuticals Reports First Quarter 2022 Financial Results

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three months ended March 31, 2022 and provides a business update. Financial results for the first quarter of 2022 include the operations of the DERMAdoctor business, which was acquired on November 5, 2021. “Total sales grew 46% during the first quarter and Avenova Spray unit sales increased 15% with record-high unit sales through the over-the-counter (OTC) channel,” said Ju